To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbDishman Carbogen Amcis Ltd Share Price
breadcrumbResults

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on March 31, 2025Data in Crores of INR
Revenue
₹ 716.34+9.41% from last year
Operating profits
₹ 160.66+130.04% from last year
Net income
₹ 43.09+161.63% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Net worth5627.505809.675548.945698.825715.065379.095107.334813.98
Fixed assets6720.086183.175768.145693.345672.855092.375060.704847.25
Debt1964.401824.511420.791165.891056.161042.181094.82949.71
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Operating383.97265.95354.85512.66585.14282.03226.44302.65
Investing -229.52-494.08-618.53-380.02-441.74-169.02-297.16-142.41
Financing -22.15249.68130.37-11.04-97.78-102.2077.63-137.08

Financial ratios

Profitability ratiosinfo2
ROA-1.61%
ROE-2.68%
ROCE-0.03%
EPS-9.79%
Net profit margin-5.87%
Operating profit margin12.03%
Dividend per share
Operational ratiosinfo2
Quick ratio0.41%
Current ratio0.75%
Interest coverage-0.02%
Assets turnover0.28%
Debt to equity0.35%
Valuation ratiosinfo2
P/E ratio
P/B ratio0.7%
Dividend yield
EV/EBITDA
Dishman Carbogen Amcis Limited (DCAL), incorporated in 1983, started out as a manufacturer of quaternary ammonium and phosphate compounds. Currently, the company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.
personal

Grow your wealth with more research recommendations

+91